145 related articles for article (PubMed ID: 31369723)
1. The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.
Schreiner AD; Bian J; Zhang J; Haulsee ZM; Marsden J; Durkalski-Mauldin V; Mauldin PD; Moran WP; Rockey DC
Am J Med; 2020 Feb; 133(2):214-221.e1. PubMed ID: 31369723
[TBL] [Abstract][Full Text] [Related]
2. A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study.
Southern WN; Norton B; Steinman M; DeLuca J; Drainoni ML; Smith BD; Litwin AH
BMC Infect Dis; 2015 Dec; 15():553. PubMed ID: 26626449
[TBL] [Abstract][Full Text] [Related]
3. Impact of electronic reminder systems on hepatitis C screening in primary care.
MacLean CD; Berger C; Cangiano ML; Ziegelman D; Lidofsky SD
J Viral Hepat; 2018 Aug; 25(8):939-944. PubMed ID: 29478306
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: cross-sectional analysis of a multisite retrospective cohort study.
Smith BD; Yartel AK; Krauskopf K; Massoud OI; Brown KA; Fallon MB; Rein DB
Clin Infect Dis; 2015 Apr; 60(8):1145-52. PubMed ID: 25595745
[TBL] [Abstract][Full Text] [Related]
5. Mixed cryoglobulinemia and hepatitis C virus.
Cacoub P; Fabiani FL; Musset L; Perrin M; Frangeul L; Leger JM; Huraux JM; Piette JC; Godeau P
Am J Med; 1994 Feb; 96(2):124-32. PubMed ID: 7509124
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).
Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R
Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038
[TBL] [Abstract][Full Text] [Related]
7. Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program.
Schechter-Perkins EM; Miller NS; Hall J; Hartman JJ; Dorfman DH; Andry C; Linas BP
Acad Emerg Med; 2018 Nov; 25(11):1216-1226. PubMed ID: 29851238
[TBL] [Abstract][Full Text] [Related]
8. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
Castillo I; Pardo M; Bartolomé J; Ortiz-Movilla N; Rodríguez-Iñigo E; de Lucas S; Salas C; Jiménez-Heffernan JA; Pérez-Mota A; Graus J; López-Alcorocho JM; Carreño V
J Infect Dis; 2004 Jan; 189(1):7-14. PubMed ID: 14702147
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis C infection in a large urban hospital-based sample of individuals with spinal cord injury.
Fong TL; Adkins RH; Govindarajan S; Post S; Waters RL
Arch Phys Med Rehabil; 2002 Nov; 83(11):1620-3. PubMed ID: 12422335
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for not undergoing RNA testing in patients found to have hepatitis C serology and impact of an automatic alert.
Morales-Arraez D; Alonso-Larruga A; Diaz-Flores F; García Dopico JA; de Vera A; Quintero E; Hernández-Guerra M
J Viral Hepat; 2019 Sep; 26(9):1117-1123. PubMed ID: 31077515
[TBL] [Abstract][Full Text] [Related]
11. Streamlining Screening to Treatment: The Hepatitis C Cascade of Care at Kaiser Permanente Mid-Atlantic States.
Jonas MC; Rodriguez CV; Redd J; Sloane DA; Winston BJ; Loftus BC
Clin Infect Dis; 2016 May; 62(10):1290-1296. PubMed ID: 26908812
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.
Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D
Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953
[TBL] [Abstract][Full Text] [Related]
13. Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study.
Brady JE; Liffmann DK; Yartel A; Kil N; Federman AD; Kannry J; Jordan C; Massoud OI; Nerenz DR; Brown KA; Smith BD; Vellozzi C; Rein DB
Hepatology; 2017 Jan; 65(1):44-53. PubMed ID: 27770543
[TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
[TBL] [Abstract][Full Text] [Related]
15. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human immunodeficiency virus testing in patients with hepatitis B and C infection.
Krain A; Wisnivesky JP; Garland E; McGinn T
Mayo Clin Proc; 2004 Jan; 79(1):51-6. PubMed ID: 14708948
[TBL] [Abstract][Full Text] [Related]
17. The disposition of hepatitis C antibody-positive patients in an urban hospital.
Putka B; Mullen K; Birdi S; Merheb M
J Viral Hepat; 2009 Nov; 16(11):814-21. PubMed ID: 19842281
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosis.
Cheng YL; Wang YC; Lan KH; Huo TI; Huang YH; Su CW; Lin HC; Lee FY; Wu JC; Lee SD
Ann Hepatol; 2015; 14(2):181-9. PubMed ID: 25671827
[TBL] [Abstract][Full Text] [Related]
19. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression.
Wang CS; Wang ST; Chang TT; Yao WJ; Chou P
Arch Intern Med; 2002 Apr; 162(7):811-5. PubMed ID: 11926856
[TBL] [Abstract][Full Text] [Related]
20. False-positive hepatitis C virus serology after placement of a ventricular assistance device.
Durand CM; Marr KA; Ostrander D; Subramanian A; Valsamakis A; Cox A; Neofytos D
Transpl Infect Dis; 2016 Feb; 18(1):146-9. PubMed ID: 26565742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]